SCIT Versus SLIT

Which One Do You Recommend, Doc?

Mohamad Chaaban, Ahmed Mansi, Julia Tripple, Sarah K. Wise

Research output: Contribution to journalReview article

Abstract

Allergic rhinitis is a prevalent condition that has a significant impact on the quality of life of many patients. When initial therapy fails to control the symptoms, allergen immunotherapy (AIT) has been suggested as an option by the Joint Task Force on Practice Parameters. The 2 main forms of AIT are via subcutaneous and sublingual routes, called subcutaneous immunotherapy and sublingual immunotherapy, respectively. There is debate about which is the better option for patients with each method offering its own pros and cons. We present 2 patients with allergic rhinitisAR that were deemed good candidates for AIT and explore current evidence for both subcutaneous immunotherapy and sublingual immunotherapy. The advantages and disadvantages of each method are discussed with the goal of providing a framework for the physician when deciding on AIT for their patients. In addition, we explore the use of AIT in patients with asthma and atopic dermatitis as potential patient populations that may benefit from the treatment. We use the discussion to provide recommendations regarding which method of AIT is best suited for both our patients.

Original languageEnglish (US)
Pages (from-to)442-447
Number of pages6
JournalAmerican Journal of the Medical Sciences
Volume357
Issue number5
DOIs
StatePublished - May 1 2019

Fingerprint

Immunologic Desensitization
Sublingual Immunotherapy
Immunotherapy
Advisory Committees
Joints
Quality of Life
Physicians
Therapeutics
Population

ASJC Scopus subject areas

  • Medicine(all)

Cite this

SCIT Versus SLIT : Which One Do You Recommend, Doc? / Chaaban, Mohamad; Mansi, Ahmed; Tripple, Julia; Wise, Sarah K.

In: American Journal of the Medical Sciences, Vol. 357, No. 5, 01.05.2019, p. 442-447.

Research output: Contribution to journalReview article

Chaaban, Mohamad ; Mansi, Ahmed ; Tripple, Julia ; Wise, Sarah K. / SCIT Versus SLIT : Which One Do You Recommend, Doc?. In: American Journal of the Medical Sciences. 2019 ; Vol. 357, No. 5. pp. 442-447.
@article{90752f7a919b4f20a2b0ddec93a2d4fc,
title = "SCIT Versus SLIT: Which One Do You Recommend, Doc?",
abstract = "Allergic rhinitis is a prevalent condition that has a significant impact on the quality of life of many patients. When initial therapy fails to control the symptoms, allergen immunotherapy (AIT) has been suggested as an option by the Joint Task Force on Practice Parameters. The 2 main forms of AIT are via subcutaneous and sublingual routes, called subcutaneous immunotherapy and sublingual immunotherapy, respectively. There is debate about which is the better option for patients with each method offering its own pros and cons. We present 2 patients with allergic rhinitisAR that were deemed good candidates for AIT and explore current evidence for both subcutaneous immunotherapy and sublingual immunotherapy. The advantages and disadvantages of each method are discussed with the goal of providing a framework for the physician when deciding on AIT for their patients. In addition, we explore the use of AIT in patients with asthma and atopic dermatitis as potential patient populations that may benefit from the treatment. We use the discussion to provide recommendations regarding which method of AIT is best suited for both our patients.",
author = "Mohamad Chaaban and Ahmed Mansi and Julia Tripple and Wise, {Sarah K.}",
year = "2019",
month = "5",
day = "1",
doi = "10.1016/j.amjms.2019.02.004",
language = "English (US)",
volume = "357",
pages = "442--447",
journal = "American Journal of the Medical Sciences",
issn = "0002-9629",
publisher = "Lippincott Williams and Wilkins",
number = "5",

}

TY - JOUR

T1 - SCIT Versus SLIT

T2 - Which One Do You Recommend, Doc?

AU - Chaaban, Mohamad

AU - Mansi, Ahmed

AU - Tripple, Julia

AU - Wise, Sarah K.

PY - 2019/5/1

Y1 - 2019/5/1

N2 - Allergic rhinitis is a prevalent condition that has a significant impact on the quality of life of many patients. When initial therapy fails to control the symptoms, allergen immunotherapy (AIT) has been suggested as an option by the Joint Task Force on Practice Parameters. The 2 main forms of AIT are via subcutaneous and sublingual routes, called subcutaneous immunotherapy and sublingual immunotherapy, respectively. There is debate about which is the better option for patients with each method offering its own pros and cons. We present 2 patients with allergic rhinitisAR that were deemed good candidates for AIT and explore current evidence for both subcutaneous immunotherapy and sublingual immunotherapy. The advantages and disadvantages of each method are discussed with the goal of providing a framework for the physician when deciding on AIT for their patients. In addition, we explore the use of AIT in patients with asthma and atopic dermatitis as potential patient populations that may benefit from the treatment. We use the discussion to provide recommendations regarding which method of AIT is best suited for both our patients.

AB - Allergic rhinitis is a prevalent condition that has a significant impact on the quality of life of many patients. When initial therapy fails to control the symptoms, allergen immunotherapy (AIT) has been suggested as an option by the Joint Task Force on Practice Parameters. The 2 main forms of AIT are via subcutaneous and sublingual routes, called subcutaneous immunotherapy and sublingual immunotherapy, respectively. There is debate about which is the better option for patients with each method offering its own pros and cons. We present 2 patients with allergic rhinitisAR that were deemed good candidates for AIT and explore current evidence for both subcutaneous immunotherapy and sublingual immunotherapy. The advantages and disadvantages of each method are discussed with the goal of providing a framework for the physician when deciding on AIT for their patients. In addition, we explore the use of AIT in patients with asthma and atopic dermatitis as potential patient populations that may benefit from the treatment. We use the discussion to provide recommendations regarding which method of AIT is best suited for both our patients.

UR - http://www.scopus.com/inward/record.url?scp=85063945216&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85063945216&partnerID=8YFLogxK

U2 - 10.1016/j.amjms.2019.02.004

DO - 10.1016/j.amjms.2019.02.004

M3 - Review article

VL - 357

SP - 442

EP - 447

JO - American Journal of the Medical Sciences

JF - American Journal of the Medical Sciences

SN - 0002-9629

IS - 5

ER -